SCHEMBL5762899

SCHEMBL5762899

CC(C)(C)OC(=O)N1CCN(c2nccc3cc[nH]c23)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.47
KIT P10721 2/20 0.46
CKS1B P61024 2/20 0.46
SKP1 P63208 2/20 0.46
SKP2 Q13309 2/20 0.46
GRIA1 P42261 1/20 0.45
DDB1 Q16531 1/20 0.45
CRBN Q96SW2 1/20 0.45
GBA1 P04062 2/20 0.45
GPR119 Q8TDV5 4/20 0.44
PDE10A Q9Y233 1/20 0.44
MAP4K4 O95819 1/20 0.44
POLB P06746 1/20 0.44
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
MAPT P10636 1/20 0.43
CHRNA7 P36544 1/20 0.42
OPRM1 P35372 1/20 0.42
OPRD1 P41143 1/20 0.42
OGFRL1 Q5TC84 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2799484 0.81 KIT (0.53) KITCKS1BSKP1SKP2GBA1
SCHEMBL1774609 0.81 KIT (0.51) ACHEKITCKS1BSKP1SKP2
SCHEMBL5760446 0.81 AKT1 (0.52) ACHEKITCKS1BSKP1SKP2
SCHEMBL5205461 0.80 IDO1 (0.48) ACHECKS1BSKP1SKP2GPR119
SCHEMBL30885785 0.80 IDO1 (0.48) ACHECKS1BSKP1SKP2GPR119
SCHEMBL6643738 0.79 CKS1B (0.50) CKS1BSKP1SKP2PDE10AOPRM1
SCHEMBL1255986 0.79 ACHE (0.59) ACHEKITCKS1BSKP1SKP2
SCHEMBL5234761 0.78 KIT (0.47) ACHEKITCKS1BSKP1SKP2
SCHEMBL8560546 0.78 CKS1B (0.49) ACHEKITCKS1BSKP1SKP2
SCHEMBL31410478 0.77 KIT (0.47) KITCKS1BSKP1SKP2GRIA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1497291-B1 QUINOLINE AND AZA-INDOLE DERIVATIVES AND THEIR USE AS 5-HT6 LIGANDS GLAXO GROUP LTD (GB) 2006-11-22 EP disclosed
US-20050124626-A1 Novel compounds GLAXO GROUP LIMITED (GB) 2005-06-09 US disclosed
EP-1497291-A2 QUINOLINE AND AZA-INDOLE DERIVATIVES AND THEIR USE AS 5-HT6 LIGANDS GLAXO GROUP LIMITED (GB) 2005-01-19 EP disclosed
WO-2003080608-A2 QUINOLINE AND AZA-INDOLE DERIVATIVES AND THEIR USE AS 5-HT6 LIGANDS GLAXO GROUP LIMITED (GB) 2003-10-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124626-A1 Novel compounds AANAT, INMT, CHRNA5 ACHE 55/4885KIT 2558/4885CKS1B 1226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.